Transcutaneous bilirubin nomogram for the first 144 hours in Thai neonates

References

• Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics. 1999;103:6–14.
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297–316.
   PubMed Web of Science ®Google Scholar
• Maisels MJ, Bhutani VK, Bogen D, et al. Hyperbilirubinemia in the newborn infant > or =35 weeks. Pediatrics. 2009;124:1193–1198.
   PubMed Web of Science ®Google Scholar
• Bhutani VK, Gourley GR, Adler S, et al. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics. 2000;106:1–5.
   PubMed Web of Science ®Google Scholar
• Maisels MJ, Kring E. Transcutaneous bilirubin levels in the first 96 hours in a normal newborn population of > or =35 weeks. Pediatrics. 2006;117:1169–1173.
   PubMed Web of Science ®Google Scholar
• Mohamed I, Blanchard AC, Delvin E, et al. Plotting transcutaneous bilirubin measurements on specific transcutaneous nomogram results in better prediction of significant hyperbilirubinemia in healthy term and near-term newborns: a pilot study. Neonatology. 2014;105:306–311.
   PubMed Web of Science ®Google Scholar
• Varvarigou A, Fouzas S, Skylogianni E, et al. Transcutaneous bilirubin nomogram for prediction of significant neonatal hyperbilirubinemia. Pediatrics. 2009;124:1052–1059.
   PubMed Web of Science ®Google Scholar
• Sanpavat S, Nuchprayoon I, Smathakanee C, et al. Nomogram for prediction of the risk of neonatal hyperbilirubinemia, using transcutaneous bilirubin. J Med Assoc Thai. 2005;88:1187–1193.
   PubMedGoogle Scholar
• Johnson W, Balakrishna N, Griffiths PL. Modeling physical growth using mixed effects models. Am J Phys Anthropol. 2013;150:58–67.
   PubMed Web of Science ®Google Scholar
• De Luca D, Romagnoli C, Tiberi E, et al. Skin bilirubin nomogram for the first 96 h of life in a European normal healthy newborn population, obtained with multiwavelength transcutaneous bilirubinometry. Acta Paediatr. 2008;97:146–150.
   PubMed Web of Science ®Google Scholar
• Fouzas S, Mantagou L, Skylogianni E, et al. Transcutaneous bilirubin levels for the first 120 postnatal hours in healthy neonates. Pediatrics. 2010;125:e52–e57.
   PubMed Web of Science ®Google Scholar
• Bental YA, Shiff Y, Dorsht N, et al. Bhutani-based nomograms for the prediction of significant hyperbilirubinaemia using transcutaneous measurements of bilirubin. Acta Paediatr. 2009;98:1902–1908.
   PubMed Web of Science ®Google Scholar
• Engle WD, Lai S, Ahmad N, et al. An hour-specific nomogram for transcutaneous bilirubin values in term and late preterm Hispanic neonates. Am J Perinatol. 2009;26:425–430.
   PubMed Web of Science ®Google Scholar
• Kuboi T, Kusaka T, Kawada K, et al. Hour-specific nomogram for transcutaneous bilirubin in Japanese neonates. Pediatr Int. 2013;55:608–611.
   PubMed Web of Science ®Google Scholar
• Akahira-Azuma M, Yonemoto N, Mori R, et al. An hour-specific transcutaneous bilirubin nomogram for Mongolian neonates. Eur J Pediatr. 2015;174:1299–1304.
   PubMed Web of Science ®Google Scholar
• Yu ZB, Dong XY, Han SP, et al. Transcutaneous bilirubin nomogram for predicting neonatal hyperbilirubinemia in healthy term and late-preterm Chinese infants. Eur J Pediatr. 2011;170:185–191.
   PubMed Web of Science ®Google Scholar
• Han S, Yu Z, Liu L, et al. A model for predicting significant hyperbilirubinemia in neonates from China. Pediatrics. 2015;136:e896–e905.
   PubMed Web of Science ®Google Scholar
• Mishra S, Chawla D, Agarwal R, et al. Transcutaneous bilirubin levels in healthy term and late preterm Indian neonates. Indian J Pediatr. 2010;77:45–50.
   PubMed Web of Science ®Google Scholar
• Kaur S, Chawla D, Pathak U, et al. Predischarge non-invasive risk assessment for prediction of significant hyperbilirubinemia in term and late preterm neonates. J Perinatol. 2012;32:716–721.
   PubMed Web of Science ®Google Scholar
• Bromiker R, Goldberg A, Kaplan M. Israel transcutaneous bilirubin nomogram predicts significant hyperbilirubinemia. J Perinatol. 2017;37:1315–1318.
   PubMed Web of Science ®Google Scholar
• De Luca D, Jackson GL, Tridente A, et al. Transcutaneous bilirubin nomograms: a systematic review of population differences and analysis of bilirubin kinetics. Arch Pediatr Adolesc Med. 2009;163:1054–1059.
   PubMedGoogle Scholar
• Sarici SU, Serdar MA, Korkmaz A, et al. Incidence, course, and prediction of hyperbilirubinemia in near-term and term newborns. Pediatrics. 2004;113:775–780.
   PubMed Web of Science ®Google Scholar
• Draque CM, Sañudo A, de Araujo Peres C, et al. Transcutaneous bilirubin in exclusively breastfed healthy term newborns up to 12 days of life. Pediatrics. 2011;128:e565–e571.
   PubMed Web of Science ®Google Scholar
• Yu ZB, Han SP, Chen C. Bilirubin nomograms for identification of neonatal hyperbilirubinemia in healthy term and late-preterm infants: a systematic review and meta-analysis. World J Pediatr. 2014;10:211–218.
   PubMed Web of Science ®Google Scholar
• Charoenkwan P, Tantiprabha W, Sirichotiyakul S, et al. Prevalence and molecular characterization of glucose-6-phosphate dehydrogenase deficiency in northern Thailand. Southeast Asian J Trop Med Public Health. 2014;45:187–193.
   PubMed Web of Science ®Google Scholar
• Slaughter J, Annibale D, Suresh G. False-negative results of pre-discharge neonatal bilirubin screening to predict severe hyperbilirubinemia: a need for caution. Eur J Pediatr. 2009;168:1461–1466.
   PubMed Web of Science ®Google Scholar
• Bromiker R, Bin-Nun A, Schimmel MS, et al. Neonatal hyperbilirubinemia in the low-intermediate-risk category on the bilirubin nomogram. Pediatrics. 2012;130:e470–e475.
   PubMed Web of Science ®Google Scholar
• Mantagou L, Fouzas S, Skylogianni E, et al. Trends of transcutaneous bilirubin in neonates who develop significant hyperbilirubinemia. Pediatrics. 2012;130:e898–e904.
   PubMed Web of Science ®Google Scholar
• Bhutani VK, Stark AR, Lazzeroni LC, et al. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. J Pediatr. 2013;162:477–482.e1.
   PubMed Web of Science ®Google Scholar
• Maisels MJ, Deridder JM, Kring EA, et al. Routine transcutaneous bilirubin measurements combined with clinical risk factors improve the prediction of subsequent hyperbilirubinemia. J Perinatol. 2009;29:612–617.
   PubMed Web of Science ®Google Scholar